Purpose: Chromosome 13q14 deletion occurs in a substantial number of chronic lymphocytic leukemia (CLL) patients and it is believed to play a pathogenetic role. The exact mechanisms involved in this lesion have not yet been fully elucidated because of its heterogeneity and the imprecise knowledge of the implicated genes. This study was addressed to further contribute to the molecular definition of this lesion in CLL. Experimental Design: We applied SNP-array technology and gene expression profiling data to investigate the 13q14 deletion occurring in a panel of 100 untreated, early-stage (Binet A) patients representative of the major genetics, molecular and biological features of the disease. Results: Concordantly with FISH analysis, SNP-arrays identified 44 patients with del(13)(q14) including 11 cases with a biallelic deletion. The shorter monoallelic deletion was 635 kb long. The loss of the miR-15a/16-1 cluster occurred in all del(13)(q14) cases except in two patients with a monoallelic deletion who retained both copies. MiR-15a/16 expression was significantly down-regulated only in patients with the biallelic loss of the miRNA cluster compared to 13q normal cases. Finally, the natural grouping of SNP profiles by means of non-negative matrix factorization algorithm, showed that patients could be classified into two separate clusters mainly characterized by short/biallelic vs. wide/monoallelic 13q14 deletions. Supervised analyses of expression data demonstrated that specific transcriptional profiles are correlated with these two genomic subgroups. Conclusions: Overall, our data highlight the presence of two distinct molecular types of 13q14 deletions which may be of clinical relevance in CLL.

Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion / L. Mosca, S. Fabris, M. Lionetti, K. Todoerti, L. Agnelli, F. Morabito, G. Cutrona, A. Andronache, S. Matis, F. Ferrari, M. Gentile, M. Spriano, V. Callea, G. Festini, S. Molica, G. Lambertenghi Deliliers, S. Bicciato, M. Ferrarini, A. Neri. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 16:23(2010), pp. 5641-5653. [10.1158/1078-0432.CCR-10-0151]

Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion

L. Mosca
Primo
;
S. Fabris
Secondo
;
M. Lionetti;K. Todoerti;L. Agnelli;G. Lambertenghi Deliliers;A. Neri
Ultimo
2010

Abstract

Purpose: Chromosome 13q14 deletion occurs in a substantial number of chronic lymphocytic leukemia (CLL) patients and it is believed to play a pathogenetic role. The exact mechanisms involved in this lesion have not yet been fully elucidated because of its heterogeneity and the imprecise knowledge of the implicated genes. This study was addressed to further contribute to the molecular definition of this lesion in CLL. Experimental Design: We applied SNP-array technology and gene expression profiling data to investigate the 13q14 deletion occurring in a panel of 100 untreated, early-stage (Binet A) patients representative of the major genetics, molecular and biological features of the disease. Results: Concordantly with FISH analysis, SNP-arrays identified 44 patients with del(13)(q14) including 11 cases with a biallelic deletion. The shorter monoallelic deletion was 635 kb long. The loss of the miR-15a/16-1 cluster occurred in all del(13)(q14) cases except in two patients with a monoallelic deletion who retained both copies. MiR-15a/16 expression was significantly down-regulated only in patients with the biallelic loss of the miRNA cluster compared to 13q normal cases. Finally, the natural grouping of SNP profiles by means of non-negative matrix factorization algorithm, showed that patients could be classified into two separate clusters mainly characterized by short/biallelic vs. wide/monoallelic 13q14 deletions. Supervised analyses of expression data demonstrated that specific transcriptional profiles are correlated with these two genomic subgroups. Conclusions: Overall, our data highlight the presence of two distinct molecular types of 13q14 deletions which may be of clinical relevance in CLL.
Settore MED/15 - Malattie del Sangue
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/150297
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 41
social impact